Current Report Filing (8-k)
March 20 2020 - 4:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) March 17, 2020
RTI SURGICAL HOLDINGS, INC.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
Delaware
|
|
001-38832
|
|
83-2540607
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
520 Lake Cook Road, Suite 315,
Deerfield, Illinois
|
|
|
|
60015
|
(Address of Principal Executive Offices)
|
|
|
|
(Zip Code)
|
Registrants telephone number, including area code: (877)
343-6832
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol
|
|
Name of exchange
on which registered
|
common stock, $0.001 par value
|
|
RTIX
|
|
Nasdaq Global Select Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer
of Listing.
On March 19, 2020, RTI Surgical Holdings, Inc. (the Company or RTI) received a letter from
the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq) indicating that, as a result of the Companys delay in filing its Annual Report on Form 10-K for the fiscal year
ended December 31, 2019 (the Form 10-K), the Company is not in compliance with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1). The notification letter
has no immediate effect on the listing or trading of the Companys common stock on the Nasdaq Global Select Market.
Nasdaq indicated
that the Company must submit a plan of compliance (the Plan) within 60 calendar days, or no later than May 18, 2020, addressing how it intends to regain compliance with Nasdaqs listing rules and, if Nasdaq accepts the Plan, it
may grant an extension of up to 180 calendar days from the Form 10-K original filing due date, or until September 14, 2020, to regain compliance.
The Companys management is working diligently to complete the Form 10-K, and intends to file the
Form 10-K as soon as practicable.
Item 5.02 Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.
On March 17, 2020 the Company and Johannes W. Louw, Vice President Financial
Planning and Analysis, agreed that Mr. Louws employment with the Company would end no later than April 8, 2020.
Item 7.01.
Regulation FD Disclosure.
A press release, dated March 20, 2020, disclosing the Companys receipt of the Nasdaq notification
letter referenced above is attached hereto as Exhibit 99.1.
The information furnished in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into
any filing of the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Forward-Looking Statements
This Current Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which may
include statements regarding the Companys ability to file its Form 10-K for the year ended December 31, 2019 within the extension period. These forward-looking statements are based on
managements current expectations, estimates and projections about our industry, our managements beliefs and certain assumptions made by our management. Words such as anticipates, expects, intends,
plans, believes, seeks, estimates, variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements are not guarantees of future
performance and are based on certain assumptions including general economic conditions, as well as those within the Companys
industry, and numerous other factors and risks identified in the Companys Form 10-K for the fiscal year ended December 31, 2018 and other
filings with the SEC. Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Important factors that could cause actual results to differ materially from the anticipated results reflected
in these forward-looking statements include risks and uncertainties relating to the following: (i) uncertainty as to the scope, timing and ultimate findings of the internal investigation; (ii) the costs and expenses relating to the
internal investigation; (iii) the impact of the internal investigation on the Company, its management and operations, including potential financial impact on the Company; (iv) the risk of potential litigation or regulatory action arising
from the internal investigation and its findings or from the failure to timely file the Form 10-K; (v) the potential identification of control deficiencies, including potential material weaknesses in
internal control over financial report and the impact of the same; (vi) potential reputational damage that the Company may suffer as a result of the matters under investigation; (vii) the possibility that the Company will be unable to file
its Form 10-K within the extension period of 15 calendar days provided under Rule 12b-25 of the Securities Exchange Act of 1934; (viii) the risk that the filing of the
Form 10-K will take longer than currently anticipated; (ix) general worldwide economic conditions and related uncertainties; (x) the impact of potential global health emergencies such as COVID-19 (coronavirus); (xi) the effect and timing of changes in laws or in governmental regulations; and (xii) other risks described in our public filings with the SEC. These factors should be considered
carefully and undue reliance should not be placed on the forward-looking statements. Each forward-looking statement in this communication speaks only as of the date of the particular statement. Copies of the Companys SEC filings may be
obtained by contacting the Company or the SEC or by visiting RTIs website at www.rtix.com or the SECs website at www.sec.gov. We undertake no obligation to update these forward-looking statements except as may be required by law.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
RTI SURGICAL HOLDINGS, INC.
|
|
|
|
|
Date: March 20, 2020
|
|
|
|
By:
|
|
/s/ Joshua H. DeRienzis
|
|
|
|
|
Name:
|
|
Joshua H. DeRienzis
|
|
|
|
|
Title:
|
|
Vice President, General Counsel and Corporate Secretary
|
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Apr 2023 to Apr 2024